Will Keytruda Continue to Aid MRK's Growth in 2026 After a Strong Q1?
Bristol-Myers Squibb Co BMY
$56.39
▼ -0.11%
($-0.06)
Index member:
S&P 500
Open
$55.90
Prev Close
$56.45
Day Range
$55.85 – $56.83
52W Range
$42.52 – $62.89
Market Cap
$113.68B
P/E (TTM)
19.28
Beta
0.25
Div Yield
4.46%
EPS (TTM)
$3.36
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1980-03-17 |
| Shares Out. | 2,041,740,000 |
| Website | bms.com ↗ |
| Phone | 13026587581 |
Bristol-Myers Squibb Co is a publicly traded company under the ticker symbol BMY on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
36 analysts (2026-05-01)
📰 Latest News for BMY
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down
Bristol-Myers Strikes $15.2 Billion China Drug Deal
Mann Partners Appoints Industry Veteran David Cohen to Advisory Board
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
BMS and Hengrui forge $15.2bn alliance for early-stage drugs
Bristol Myers Squibb signs $15.2B licensing deal with Hengrui